Hims & Hers (HIMS) CEO Says the FTC Doesn’t Understand His Own Company
Hims & Hers is fighting a federal regulator's characterization of its core business at the same time it's trying to expand into AI-driven healthcare tools.
That raises the real question: is the FTC's lawsuit a real threat to how Hims & Hers operates, or a misreading of a business model regulators don't fully understand yet?
Dudum's public defense is confident. However, an active FTC lawsuit doesn't resolve itself through interviews. Investors will need the legal process, not just the CEO's framing, to know how much risk the case really carries.
While we acknowledge the potential of HIMS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock .
READ NEXT: BP p.l.c. (BP) vs. Shell plc (SHEL): Two Oil Majors Cash In on the Iran War, But Tell Different Stories and ArcelorMittal (MT) vs. Microsoft Corporation (MSFT): A Steel Giant Bets Its Future on Azure .
